Imax Corp’s recent filing unveils that its Chief Commercial Officer Dolci Giovanni M. unloaded Company’s shares for reported $0.16 million on Aug 05 ’25. In the deal valued at $25.00 per share,6,500 shares were sold. As a result of this transaction, Dolci Giovanni M. now holds 33,000 shares worth roughly $0.84 million.
Then, GIOVANNI MARIA DOLCI bought 6,500 shares, generating $162,468 in total proceeds.
Before that, Richard Gelfond bought 100,000 shares. Imax Corp shares valued at $2,714,000 were divested by the Officer at a price of $27.14 per share.
A number of analysts have revised their coverage, including Seaport Research Partners’s analysts, who began to cover the stock in late July with a ‘”a Buy”‘ rating. Barrington Research also remained covering IMAX and reiterated its “an Outperform” recommendation on April 21, 2023. B. Riley Securities maintained its rating on December 05, 2022. It rated IMAX as “a Buy”.
Price Performance Review of IMAX
On Monday, Imax Corp [NYSE:IMAX] saw its stock jump 2.50% to $25.38. Over the last five days, the stock has gained 0.12%. Imax Corp shares have risen nearly 26.39% since the year began. Nevertheless, the stocks have fallen -0.86% over the past one year. While a 52-week high of $29.66 was reached on 06/13/25, a 52-week low of $18.76 was recorded on 04/11/25.
Levels Of Support And Resistance For IMAX Stock
The 24-hour chart illustrates a support level at 24.49, which if violated will result in even more drops to 23.59. On the upside, there is a resistance level at 25.99. A further resistance level may holdings at 26.59.
How much short interest is there in Imax Corp?
A steep rise in short interest was recorded in Imax Corp stocks on 2025-07-15, growing by 0.12 million shares to a total of 4.44 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 4.32 million shares. There was a rise of 2.72%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 12, 2022 when B. Riley Securities resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $20.
